MCM
ARMP icon

MAI Capital Management’s Armata Pharmaceuticals ARMP Stock Holding History

MAI Capital Management’s Portfolio ARMP Stock Details ARMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$728 Hold
71
– – ﹤0.01% 4292
2025
Q4 		$446 Hold
71
– – ﹤0.01% 3862
2025
Q3 		$212 Hold
71
– – ﹤0.01% 3705
2025
Q2 		$135 Hold
71
– – ﹤0.01% 3883
2025
Q1 		$104 Hold
71
– – ﹤0.01% 3350
2024
Q4 		$132 Buy
+71
New +$160 ﹤0.01% 3410

Other funds holding ARMP

MAM
Madison Asset Management Madison, Wisconsin $8.06B AUM 11.81% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MAI Capital Management's ARMP Position: Q1 2026 in Review

MAI Capital Management held its Armata Pharmaceuticals (ARMP) position steady in Q1 2026 at 71 shares worth $728. The position accounts for ﹤0.01% of the portfolio, ranked #4292.

MAI Capital Management first reported a position in ARMP in Q4 2024 and has held it in 6 quarters since. 45 funds tracked by Wall St. Rank hold ARMP as of Q1 2026.

  • MAI Capital Management held 71 shares of Armata Pharmaceuticals worth $728 as of Q1 2026.
  • MAI Capital Management left its Armata Pharmaceuticals share count unchanged in Q1 2026.
  • Armata Pharmaceuticals made up ﹤0.01% of MAI Capital Management's portfolio in Q1 2026, its #4292 holding.
  • MAI Capital Management first reported a position in Armata Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • 45 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q1 2026.

Based on MAI Capital Management's 13F filing for Q1 2026, filed 15 May 2026.